Variant report
Variant | esv3481409 |
---|---|
Chromosome Location | chr8:59601399-59602646 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529018482 | chr8:59601411-59601412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs74582356 | chr8:59601414-59601415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530079636 | chr8:59601434-59601435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549328558 | chr8:59601451-59601452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73684357 | chr8:59601517-59601518 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs184789278 | chr8:59601525-59601526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1387221 | chr8:59601557-59601558 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs535714914 | chr8:59601561-59601562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs377725982 | chr8:59601624-59601625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190039360 | chr8:59601709-59601710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568581415 | chr8:59601789-59601790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537523245 | chr8:59601799-59601800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs147654108 | chr8:59601925-59601926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74968723 | chr8:59601934-59601935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537032035 | chr8:59601970-59601971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375503456 | chr8:59602011-59602012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539897149 | chr8:59602037-59602038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553586484 | chr8:59602089-59602090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368082041 | chr8:59602094-59602095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573469576 | chr8:59602150-59602151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs72647473 | chr8:59602161-59602162 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs565856004 | chr8:59602167-59602168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531156887 | chr8:59602193-59602194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs377405143 | chr8:59602194-59602195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544708111 | chr8:59602203-59602204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192129050 | chr8:59602213-59602214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530054798 | chr8:59602238-59602239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184677492 | chr8:59602245-59602246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189393021 | chr8:59602246-59602247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181979403 | chr8:59602249-59602250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185166227 | chr8:59602267-59602268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552078372 | chr8:59602309-59602310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs4738702 | chr8:59602331-59602332 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs537692408 | chr8:59602346-59602347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547879557 | chr8:59602368-59602369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568067088 | chr8:59602391-59602392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376022744 | chr8:59602456-59602457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189201422 | chr8:59602516-59602517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs553504470 | chr8:59602524-59602525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181093571 | chr8:59602530-59602531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186331773 | chr8:59602534-59602535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559332952 | chr8:59602549-59602550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs149031099 | chr8:59602561-59602562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544822009 | chr8:59602585-59602586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561391746 | chr8:59602592-59602593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs574849613 | chr8:59602597-59602598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs540590573 | chr8:59602607-59602608 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
48 | rs143006521 | chr8:59602615-59602616 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532402953 | chr8:59602639-59602640 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 22183965 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:59588200-59601600 | Weak transcription | K562 | blood |
2 | chr8:59600600-59601400 | Enhancers | Fetal Intestine Small | intestine |
3 | chr8:59601600-59602200 | Enhancers | K562 | blood |
4 | chr8:59602200-59602600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr8:59602600-59603200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |